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Chronic kidney disease is considered an inflammatory
state and a high fiber intake is associated with decreased
inflammation in the general population. Here, we determined
whether fiber intake is associated with decreased
inflammation and mortality in chronic kidney disease, and
whether kidney disease modifies the associations of fiber
intake with inflammation and mortality. To do this, we
analyzed data from 14,543 participants in the National Health
and Nutrition Examination Survey III. The prevalence of
chronic kidney disease (estimated glomerular filtration rate
less than 60ml/min per 1.73m2) was 5.8%. For each 10-g/day
increase in total fiber intake, the odds of elevated serum
C-reactive protein levels were decreased by 11% and 38%
in those without and with kidney disease, respectively.
Dietary total fiber intake was not significantly associated
with mortality in those without but was inversely related to
mortality in those with kidney disease. The relationship
of total fiber with inflammation and mortality differed
significantly in those with and without kidney disease. Thus,
high dietary total fiber intake is associated with lower risk of
inflammation and mortality in kidney disease and these
associations are stronger in magnitude in those with kidney
disease. Interventional trials are needed to establish the
effects of fiber intake on inflammation and mortality in
kidney disease.
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There are more than 16 million1 US adults with chronic
kidney disease (CKD) defined as estimated glomerular
filtration rate (eGFR) o60ml/min per 1.73m2. CKD is
considered an independent risk factor for cardiovascular
disease.2–5 Furthermore, CKD is also considered to be an
inflammatory milieu,6 and elevated levels of serum C-reactive
protein (CRP) is a strong predictor of cardiovascular events
and mortality in CKD.7–10 Therefore, it is of great interest
to identify potential interventions that could decrease the
elevated serum CRP levels that are commonly seen in the
CKD population. One such potential, but simple interven-
tion, is increase in dietary fiber intake, as many studies in the
general population suggest that high dietary fiber intake is
associated with lower serum levels of markers of inflamma-
tion11,12 as well as decreased risk of mortality.13,14 However,
dietary fiber intake is often low in the CKD population
because of decreased intake of fruits and vegetables. To our
knowledge, the associations of fiber intake with inflammation
and mortality have not been studied in the CKD population.
Therefore, we used the National Health and Nutrition
Examination Survey (NHANES III) database to examine
the associations of dietary fiber (total, soluble, and insoluble)
intake with elevated serum CRP (43mg/l) and all-cause
mortality in the non-CKD and CKD populations. We also
examined whether the presence of CKD modifies the associ-
ations of fiber intake with serum CRP and mortality.
RESULTS
Baseline characteristics
The study population consisted of 14,533 adult participants
aged 20 years or older with eGFR o150ml/min per 1.73m2
and non-missing data for dietary fiber intake. The mean
(±s.d.) age was 45.0±15.8 years and 48% were men and
10% were African American. The mean intakes of total,
soluble, and insoluble dietary fibers were 17.4±9.7, 6.0±3.3,
and 11.3±6.8 g/day, respectively.
The prevalence of CKD was 5.8%. On the basis of the
median total fiber intake of 14.6 g/day in the entire cohort,
both non-CKD and CKD participants were divided into low-
and high-fiber intake groups (Table 1). In general, in both
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non-CKD and CKD populations, male gender was associated
with higher fiber intake, whereas African-American race was
associated with lower fiber intake. None of the comorbid
conditions was associated with fiber intake. Of the lifestyle
factors, smoking and physical inactivity were associated with
low fiber intake, and alcohol use was associated with high
fiber intake. As expected, high total fiber intake was
associated with higher intake of both soluble and insoluble
fibers as well as calorie and protein intakes (Table 2) in both
CKD and non-CKD populations.
Dietary fiber and elevated CRP in the entire cohort, and
non-CKD, and CKD sub-populations
In the entire population, 25.7% had elevated (43mg/l)
serum CRP. The CKD sub-population had a higher
prevalence of elevated serum CRP compared with the non-
CKD sub-population (44.5 vs. 24.5%, Po0.001).
Intake of total, insoluble, and soluble fibers was each
inversely associated with elevated serum CRP in unadjusted
models (Table 3) in the entire cohort. Adjustment for factors
that are potential confounders and unlikely to be in the
causal pathway between fiber intake and elevated CRP
(model 2 in Table 3) modestly attenuated these associations.
Further adjustment for abdominal obesity and diabetes had
little impact on the odds ratios (model 3 in Table 3).
The associations of total, insoluble, and soluble fiber
intakes with elevated serum CRP in the non-CKD and CKD
sub-populations are summarized in Figure 1. Adjustment
for the potential confounders, including age, gender, race,
myocardial infarction, congestive heart failure, stroke, cancer,
Table 1 | Baseline characteristicsa of non-CKD and CKD participants according to dietary total fiber intake
Non-CKD (X60ml/min per 1.73m2) CKD (o60ml/min per 1.73m2)
Low total fiber
(o14.5 g/day;
n=6523)
High total fiber
(X14.6 g/day;
n=6915) P
Low total fiber
(o14.5 g/day;
n=623)
High total fiber
(X14.6 g/day;
n=482) P
Total dietary fiber (g/day) 9.5±3.1 24.4±8.9 9.5±3.7 22.7±7.7
Demographics
Age (years) 43±15 44±14 0.001 69±15 70±12 0.53
Men (%) 37 (35–39) 59 (57–60) o0.001 27 (22–32) 48 (42–55) o0.001
African Americans (%) 14 (12–15) 8 (7–9) o0.001 10 (7–13) 4 (2–6) 0.004
Clinical characteristics
Myocardial infarction (%) 2.5 (2.1–3.1) 3.0 (2.4–3.8) 0.29 15.9 (11.8–21.2) 14.9 (10.6–20.5) 0.76
Stroke (%) 1.6 (1.2–2.2) 1.5 (1.1–1.9) 0.61 7.7 (5.8–10.3) 10.8 (7.5–15.3) 0.15
Congestive heart failure (%) 1.6 (1.3–2.0) 1.5 (1.1–2.0) 0.75 13.5 (10.3–17.4) 11.1 (7.5–16.2) 0.43
Malignancy (%) 3.5 (2.9–4.2) 3.5 (3.1–4.0) 0.96 12.0 (8.7–16.4) 9.0 (5.9–13.6) 0.30
Diabetes mellitus (%) 6.6 (5.7–7.7) 6.1 (5.3–7.1) 0.423 21.3 (17.1–26.5) 19.9 (15.8–24.8) 0.719
Current smoker (%) 34 (32–35) 25 (23–28) o0.001 17 (14–21) 9 (6–13) 0.001
Alcohol use (%) 52 (49–55) 59 (55–62) o0.001 22 (18–28) 38 (30–47) 0.001
Leisure-time physical inactivity (%) 16 (15–18) 11 (10–13) o0.001 34 (28–41) 20 (15–27) 0.003
Waist circumference of men (inches) 37.2±4.9 37.1±4.4 0.77 39.5±5.4 39.4±4.3 0.87
Waist circumference of women (inches) 34.5±5.5 34.3±5.3 0.28 37.3±5.2 37.7±5.4 0.48
Systolic blood pressure (mmHg) 121±16 122±15 0.002 142±23 140±22 0.26
Diastolic blood pressure (mmHg) 74±9 75±9 o0.001 75±13 75±12 0.94
Laboratory
Serum C-reactive protein 43mg/l (%) 28 (25–30) 22 (20–24) o0.001 48 (42–54) 40 (34–47) 0.08
eGFR (ml/min per 1.73m2) 95±17 93±16 0.004 49±10 50±10 0.22
Serum triglycerides (mg/dl) 135±92 144±108 0.005 199±146 195±123 0.68
Serum HDL cholesterol (mg/dl) 51±15 51±14 0.31 49±17 49±18 0.95
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein.
aMean±s.d. or median (25th to 75th percentiles) for continuous variables and proportion (95% confidence interval) for dichotomous variables are presented.
Table 2 | Baseline dietary factorsa of non-CKD and CKD participants according to dietary total fiber intake
Non-CKD (X60ml/min per 1.73m2) CKD (o60ml/min per 1.73m2)
Low total fiber
(o14.5 g/day;
48.5%)
High total fiber
(X14.6 g/day;
51.5%) P
Low total fiber
(o14.5 g/day;
56.4%)
High total fiber
(X14.6 g/day;
43.6%) P
Soluble fiber (g/day) 3.5±1.3 8.2±3.1 o0.001 3.6±1.6 7.7±2.7 o0.001
Insoluble fiber (g/day) 5.9±2.1 16.0±6.4 o0.001 5.9±2.5 14.9±6.1 o0.001
Calorie intake (cal/day) 1721±682 2658±1009 o0.001 1329±558 1987±792 o0.001
Protein intake (g/day) 65±31 98±42 o0.001 52±25 78±37 o0.001
Abbreviations: CKD, chronic kidney disease; cal, calories.
aMean±s.d. or median (25th to 75th percentiles) for continuous variables and proportion (95% confidence interval) for dichotomous variables are presented.
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smoking, alcohol use, leisure-time physical inactivity, systolic
blood pressure, diastolic blood pressure, calorie and protein
intakes, serum triglycerides, serum high-density lipoprotein,
serum low-density lipoprotein cholesterol (but not factors
on the causal pathways between fiber intake and CRP such
as waist circumference and diabetes), and total, soluble, and
insoluble fiber intakes, was each inversely associated with
the risk of elevated serum CRP in both the CKD and non-
CKD populations, but was significantly stronger in those
with CKD than those without CKD (interaction P-values
were 0.002 for total fiber, 0.008 for soluble, and 0.005 for
insoluble fiber).
Dietary fiber and all-cause mortality in entire cohort, and
non-CKD and CKD cohort
Out of 14,533 NHANES III participants included in the
analysis there were 2141 deaths (14.7%) over an average
follow-up of 8.4 years. The non-CKD sub-population
consisted of 13,428 participants with 1549 deaths (11.5%)
over an average follow-up of 8.6 years. The CKD sub-
population of 1,105 participants had 592 deaths (54%) over
an average follow-up of 6.5 years. Table 4 summarizes the
associations of dietary fiber with all-cause mortality in the
entire cohort. In the unadjusted analyses, intake of total,
insoluble, and soluble fibers was inversely associated with
mortality in the entire cohort. However, after adjusting
for demographics, comorbidities, and lifestyle factors this
association was nonsignificant.
As shown in Figure 2, there was no association of fiber
intake with mortality within the non-CKD sub-population
adjusted for potential confounders (age, gender, race,
smoking, alcohol, physical activity, and calorie and protein
intakes). However, within the CKD sub-population, in
similar models, intakes of total and insoluble fiber were
Table 3 | Associations of dietary fiber intake with elevated
serum CRP (43mg/l) in the entire cohort
Total fiber Insoluble fiber Soluble fiber
For each
10-g/day m
For each
10-g/day m
For each
10-g/day m
OR (95% CI) OR (95% CI) OR (95% CI)
Model 1a 0.79 (0.74, 0.83) 0.73 (0.68, 0.79) 0.48 (0.42, 0.57)
Model 2b 0.87 (0.81, 0.94) 0.84 (0.76, 0.93) 0.67 (0.54, 0.83)
Model 3c 0.88 (0.81, 0.96) 0.86 (0.77, 0.96) 0.69 (0.54, 0.87)
Abbreviations: CI, confidence interval; CRP, C-reactive protein; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; OR, odds ratio.
aUnadjusted.
bAdjusted for age, gender, race, myocardial infarction, congestive heart failure,
stroke, cancer, smoking, alcohol use, leisure-time physical inactivity, systolic blood
pressure, diastolic blood pressure, calorie intake, protein intake, serum triglycerides,
serum HDL cholesterol, and serum LDL cholesterol.
cAdjusted for above+waist circumference and diabetes mellitus.
Total fiber
Insoluble fiber
Soluble fiber
0.06 0.13 0.25 1.00 2.000.50
0.26
0.72
0.87
0.55
0.62
0.89
CKD
Non-CKD
CKD
Non-CKD
CKD
Non-CKD
Figure 1 |Associations of dietary fiber with elevated serum
C-reactive protein (43mg/l) in the non-chronic kidney
disease (CKD) and CKD sub-populations. Odds ratio for every
10-g/day increase in each type of fiber intake in CKD and non-CKD
sub-populations. Models adjusted for age, gender, race,
myocardial infarction, congestive heart failure, stroke, cancer,
smoking, alcohol use, leisure-time physical inactivity, systolic
blood pressure, diastolic blood pressure, calorie and protein
intakes, serum triglycerides, serum high-density lipoprotein
cholesterol, and serum low-density lipoprotein cholesterol.
Table 4 | Associations of dietary fiber intake with all-cause
mortality in the entire cohort
Total fiber Insoluble fiber Soluble fiber
For each
10-g/day m
For each
10-g/day m
For each
10-g/day m
HR (95% CI) HR (95% CI) HR (95% CI)
Model 1a 0.91 (0.85, 0.97) 0.90 (0.82, 0.99) 0.72 (0.61, 0.85)
Model 2b 0.98 (0.92, 1.06) 0.98 (0.89, 1.07) 0.98 (0.81, 1.18)
Model 3c 1.00 (0.93 1.07) 1.00 (0.91, 1.09) 0.98 (0.81, 1.19)
Model 4d 1.00 (0.93, 1.08) 0.99 (0.90, 1.10) 1.04 (0.85, 1.26)
Abbreviations: CI, confidence interval; CRP, C-reactive protein; HDL, high-density
lipoprotein; HR, hazard ratio; LDL, low-density lipoprotein.
aUnadjusted.
bAdjusted for age, gender, race, smoking, alcohol, leisure-time physical inactivity,
calorie intake, and protein intake.
cModel 2+adjusted for myocardial infarction, congestive heart failure, stroke, cancer,
diabetes, systolic and diastolic blood pressure, serum triglycerides, serum HDL
cholesterol, and serum LDL cholesterol.
dModel 3+adjusted for waist circumference and serum CRP.
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Figure 2 |Associations of dietary fiber with all-cause mortality in
the chronic kidney disease (CKD) and non-CKD sub-populations.
Hazard ratio for every 10-g/day increase in each type of fiber
intake in CKD and non-CKD sub-populations. Models adjusted for
age, gender, race, smoking, alcohol, leisure-time physical
inactivity, and calorie intake and protein intakes.
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inversely associated with risk of death, whereas this reached
nonsignificance for the soluble fiber (Figure 2). Interaction
P-values for CKD on the associations of fiber intake with
mortality were 0.006 for total, 0.09 for soluble, and 0.004 for
insoluble fibers. In additional sensitivity analyses, after
adjusting for factors that are in the potential causal pathway
between fiber intake and mortality (myocardial infarction,
congestive heart failure, stroke, cancer, hypertension, systolic
and diastolic blood pressures, and fasting serum lipids),
each 10-g/day increase was associated with hazard ratio
(HR) 0.83, 95% confidence interval (CI) 0.73–0.94 for total
fiber, HR 0.77, 95% CI 0.65–0.91 for insoluble fiber, and HR
0.67, 95% CI 0.42–1.04 for soluble fiber. With further
adjustment for serum CRP levels and waist circumference,
the corresponding HR and 95% CI for total, insoluble, and
soluble fibers were (HR 1.00, 95% CI 0.93–1.08), (HR 0.99,
95% CI 0.90–1.10), and (HR 1.04, 95% CI 0.85–1.26),
respectively.
DISCUSSION
The results of this study suggest that in the non-CKD
population, higher fiber intake was associated with lower
inflammation but not lower mortality. On the other hand, in
the CKD population, higher fiber intake not only had strong
association with lower inflammation but also was associated
with lower mortality. The following discussion interprets
these findings in the context of existing literature.
To our knowledge, there are no guidelines for dietary
fiber intake in CKD population. In the general population,
the current guidelines recommend a total fiber (both soluble
and insoluble) intake of 20–35 g/day.15 However, the average
American currently consumes one-half this amount.11,12,16
The current national guidelines for fiber intake are based
on observational data.
Higher dietary fiber intake was associated with lower
serum levels of interleukin-6 and tumor necrosis factor-alpha
receptor-2 in postmenopausal women in the Women’s Health
Initiative Study.17 Dietary fiber intake was associated with
lower serum CRP in cross-sectional studies11,12 as well as in
longitudinal analyses18 in the general population. These data
raise the question whether dietary fiber per se or the other
nutrients that are present in the foods that are high in fiber
decrease systemic inflammation. King et al.19 examined the
effects of fiber intake on serum CRP levels in a randomized
crossover intervention trial of two diets, a high-fiber
(30 g/day) Dietary Approaches to Stop Hypertension diet or
fiber-supplemented diet (30 g/day). Overall, the mean serum
CRP level changed from 4.4 to 3.8mg/l (13.7%; P¼ 0.046)
in the high-fiber Dietary Approaches to Stop Hypertension
diet group and to 3.6mg/l (18.1%; P¼ 0.03) in the fiber-
supplemented diet group. However, in another trial of
7 g/day or 14 g/day of fiber supplementation, there were
no changes in serum levels of markers of inflammation
compared with the control group in overweight or obese
adults.20 It is unclear whether the differences in these two
studies reflect the different doses of fiber supplementation.
Several mechanisms have been proposed for the associa-
tion of high dietary fiber intake with decreased serum CRP.
Dietary fiber may inhibit inflammation by lowering glycemic
load of rapidly digestible and absorbable dietary carbohy-
drates.21,22 High-fiber diet has been associated with higher
plasma levels of anti-inflammatory adiponectin.23 Further-
more, substances such as phenols, indoles, and amines
produced by colonic bacterial metabolism are absorbed from
the gut and might have a role in systemic inflammation.24
These bacterial metabolism end products are normally
cleared by the kidney but they accumulate with kidney
failure. This might explain the observation that the associa-
tions of higher dietary fiber with lower inflammation are
stronger in the CKD population than in the non-CKD
population, as a high-fiber diet by altering gut bacterial
metabolism likely decreases the generation and absorption
of these toxins, and thereby, decreases systemic concentra-
tions of these toxins more in the CKD population than in the
non-CKD population.
Chronic metabolic acidosis is a complication of CKD and
is associated with elevated CRP.25 This is further worsened in
the CKD population because of the low intake of fruits and
vegetables, which are an important source of alkali.26
Exposure of macrophages to an acidic environment leads
to the increased production of tumor necrosis factor-a. In
one study, the correction of metabolic acidosis in a small
number of patients maintained on chronic ambulatory
peritoneal dialysis was associated with a reduction in tumor
necrosis factor-a levels.27
In the current study, higher dietary fiber intake was
associated with decreased mortality in the CKD but not in
the non-CKD population. Furthermore, this association
of higher fiber intake with lower mortality in CKD was
independent of demographics, cardiovascular disease, other
lifestyle factors, blood pressure, serum lipids, and calorie and
protein intakes. Further adjustment for serum CRP levels
eliminated the association of fiber intake with mortality
in CKD. Taken together, these data suggest a stronger role
of dietary fiber in lowering inflammation in the CKD
population and this is a likely potential mechanism for the
association of higher dietary fiber with lower mortality in this
population.
Nonetheless, apart from inflammation, there are other
potential mechanisms through which dietary fiber could
improve survival. Higher intake of whole grain foods
or cereal fiber was consistently associated with lower risk of
incident diabetes in prospective observational studies.28
Higher cereal fiber intake was associated with slower
angiographic progression of coronary artery disease29 and
lower risk of incidence of total stroke and ischemic stroke.30
Higher dietary fiber intake was associated with lower risk of
coronary heart disease mortality.31 In NHANES I Epidemio-
logical Follow-up Study, dietary fiber in particular soluble
fiber was associated with lower risk of subsequent incidence
of coronary heart disease and cardiovascular disease events.32
Fruit intake with lower mortality in elderly.33
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Although there is mounting evidence from observational
studies on the role of dietary fiber in reducing inflammation,
diabetes, and cardiovascular disease, caution is needed in
interpreting these results. First, whether dietary fiber per se or
the other nutrients that are present in the foods that are high
in fiber provide the health benefits is difficult to establish in
the absence of interventional trials that increase dietary fiber
alone. Second, whether the soluble fibers (from sources such
as psyllium, fruits, vegetables, oatmeal, beans, and peas) or
insoluble fibers (from sources such as wheat bran, whole
grains, oats, and cereals) or both result in decrease in
inflammation and cardiovascular disease is unclear. Third,
even though observational studies might suggest benefit
that might not be observed in interventional trials. For
instance, among survivors of early-stage breast cancer,
adoption of a diet that was very high in vegetables, fruit,
and fiber and low in fat did not reduce additional breast
cancer events or mortality during a 7.3-year follow-up
period.34 Dietary advice to increase cereal intake in men
after myocardial infarction was not associated with improved
outcomes.35
There are other limitations to the current study; first,
it is an observational, retrospective analysis of an existing
database, which limits causal inference. Second, residual
confounding due to unmeasured confounders cannot be ruled
out. This is a major limitation of this type of analyses. Third,
the diet was assessed with the use of a single 24-h-diet recall.
In conclusion, this study suggests a stronger inverse
association of dietary fiber intake with inflammation and all-
cause mortality in the CKD population than in the non-CKD
population. Further studies are warranted to determine the
mechanisms of these associations. Interventional trials are
warranted to establish the causal role of dietary fiber in
reducing inflammation and mortality in the CKD population.
MATERIALS AND METHODS
From 1988 to 1994, the National Center for Health Statistics
conducted NHANES III, a cross-sectional survey of the US
population. A complex, multistage sampling design was used to
extrapolate the results to the entire non-institutionalized civilian US
population as of the early 1990s.36 Data on age, sex, race, current or
past cigarette smoking, and history of comorbid conditions, such as
myocardial infarction, stroke, and congestive heart failure, were
collected in a structured home interview conducted by trained
personnel. A detailed questionnaire on leisure-time physical activity
was also administered during the home interview. The home
interview was followed by an examination by a physician at a mobile
examination center, which included blood pressure measurement,
extensive anthropometric, physiological, and laboratory testing.
Serum specimens from collection sites were transported on dry
ice to the central laboratories and stored at 70 1C until analysis.
Serum CRP was measured by latex-enhanced nephelometry using a
Behring Nephelometer Analyzer System and reagents from Behring
Diagnostics, Somerville, NJ. The lower limit for detection of this
assay was 2.1mg/dl. Serum creatinine was measured using a kinetic
rate Jaffe method in NHANES III. These serum creatinine
measurements were recalibrated to standardized creatinine
measurements obtained at the Cleveland Clinic Research Laboratory
(Cleveland, OH) as standard creatinine (¼0.184þ 0.960
NHANES III measured serum creatinine in mg/dl).2 eGFR was
calculated as 175 (standardized serum creatinine)1.154
(age)0.203 0.742 (if the individual is woman) 1.212 (if the
individual is African American) ml/min per 1.73m2. CKD was
defined as eGFR o60ml/min per 1.73m2.
Details about dietary assessment methodology have been
published elsewhere.37 A computer-based interview system devel-
oped by the University of Minnesota’s Nutrition Coordinating
Center (Regents of the University of Minnesota) was used to
conduct a 24-h dietary recall. The 24-h dietary recall was conducted
by trained interviewers. The US Department of Agriculture’s Survey
Nutrient DataBase was used to calculate macro- and micronutrient
content of the foods consumed during the 24-h recall period for
each respondent.
Follow-up data
The National Center for Health Statistics created a NHANES III
Linked Mortality File that contains mortality follow-up data from
the date of NHANES III survey participation (1988–1994) through
31 December 2000. This information was based upon the results
from a probabilistic match between NHANES III and National
Death Index death certificate records, the details of which
are provided elsewhere.37
Data analyses
Several aspects of the NHANES design must be taken into account in
data analysis, including the sampling weights and the complex
survey design. We used the svy suite of commands in Stata 11
(Stata 11, College Station, TX) and followed the analytical guidelines
for NHANES data proposed by the Centers for Disease Control and
Prevention.37 It should be noted that the svy suite of commands in
Stata use the complex survey design of NHANES to calculate the
expected means and proportions of the entire US non-institutional-
ized civilian CKD population, and hence, means and proportions are
presented with the estimated value and 95% confidence intervals.
Chi-square tests and t-tests (with adjustments for the survey
design as implemented by the svy commands in Stata 11) were used
as appropriate to compare categorical and continuous baseline
factors between the low- and high-fiber groups within the non-CKD
and CKD participants.
Associations of fiber intake with elevated serum CRP
Serum CRP 43mg/l was defined as elevated CRP in this study
based upon a consensus statement of the Centers for Disease
Control and the American Heart Association.38 The association of
total fiber with elevated serum CRP was first examined without
covariate adjustment in the entire cohort with a logistic regression
model. Next, this model was expanded by adding covariates to
adjust for factors that are likely potential confounders and unlikely
to be in the causal pathway between fiber and elevated CRP. These
variables were age, gender, race, myocardial infarction, congestive
heart failure, stroke, cancer, smoking, alcohol use, leisure-time
physical inactivity, systolic blood pressure, diastolic blood pressure,
calorie and protein intakes, serum triglycerides, serum high-density
lipoprotein, and serum low-density lipoprotein cholesterol.
In sensitivity analysis, factors that are potential confounders
but also may fall in the causal pathway between fiber and elevated
CRP were added to the above covariates. These factors were waist
circumference and diabetes.
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The above analyses were repeated separately for soluble and
insoluble fibers in the entire cohort.
To examine the effect modification by CKD of the associations of
fiber intake with elevated CRP, the above analyses were conducted
separately in the non-CKD and CKD sub-populations and the
regression coefficients of fiber intake with elevated CRP in the non-
CKD and CKD sub-populations were compared using a large-
sample normal approximation.
Associations of fiber intake with mortality
The association of total fiber with mortality was first examined in
the entire cohort with a Cox regression model without covariate
adjustment. Next this model was extended by adding covariates that
are potential confounders and unlikely to be in the causal pathway
between fiber and mortality. These variables were age, gender, race,
smoking, alcohol use, leisure-time physical inactivity, calorie and
protein intakes.
In sensitivity analysis, factors that are potentially in the causal
pathway between fiber and mortality were added to the above
covariates. These variables were myocardial infarction, congestive
heart failure, stroke, cancer, systolic blood pressure, diastolic blood
pressure, serum triglycerides, serum high-density lipoprotein and
serum low-density lipoprotein cholesterol, and diabetes. In order
to examine the extent to which serum CRP and abdominal obesity
potentially mediate the associations of dietary fiber with mortality,
serum CRP, and waist circumference were added to the above
model.
It is unlikely that the association of dietary fiber with
inflammation is mediated by cardiovascular disease, cancer, blood
pressure, and serum lipids. On the other hand, these variables could
mediate the association of fiber with mortality. Therefore, we chose
a different order of variables for the main model and the sensitivity
analyses for elevated CRP and mortality.
Similarly, to the analyses of CRP, the Cox regressions for
mortality were repeated for soluble and insoluble fibers in the entire
cohort, and each models was then fit separately in the non-CKD and
CKD sub-populations to evaluate if the relationships of mortality
with the fiber intake factors differed between the non-CKD and
CKD sub-populations.
The assumption of proportional hazards was examined by
comparing the logarithm of the hazard ratio for each predictor
variable in the first 36 months of follow-up to the logarithm
of the hazard ratio of the predictor variables after 36 months. The
factors age, gender, and serum CRP exhibited a significant deviation
from proportional hazards for mortality (Po0.05). Hence, the
Cox regressions were stratified by each of these factors (using
tertiles for the continuous variables age and serum CRP) to allow
separate baseline hazard functions within each stratum. Further-
more, within each age stratum, age was adjusted as a continuous
variable.
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